Not every hospital, trial site or BA/BE centre has its own ethics committee, and those that do often struggle with meeting delays. The Independent Ethics Committee (IEC) of Saanvi Ethical Research reviews clinical trials and bioavailability/bioequivalence (BA/BE) studies for sites across Delhi NCR, with a documented, SOP-driven process and predictable timelines.
CDSCO Registered
Reg. No. ECR/314/Indt/UP/2019/RR-24
Re-registered 25 July 2025, valid until September 2029
Registered With US HHS (OHRP)
IORG0012586 / IRB00014886
Based in New Delhi
A-253, First Floor, Main Chhatarpur Road, New Delhi 110074
Who We Work With
Hospitals and investigator sites without an institutional ethics committee, BA/BE centres, and sponsors and CROs placing studies in Delhi NCR.
Under the New Drugs and Clinical Trials Rules, 2019, a site without its own ethics committee can use a registered ethics committee within 50 km. From Chhatarpur, that covers most sites in Delhi, Gurugram, Noida, Faridabad and Ghaziabad.
What We Review
- Initial protocols, investigator’s brochures and informed consent documents, including translations
- Protocol amendments and new versions of consent forms
- Serious adverse event reports, with causality and compensation assessment
- Protocol deviations and violations, and GCP non-compliance
- Continuing (periodic) review and study closure reports
How Ethics Review Works
Submit Your Dossier
Email it to info@saanviethical.com. We’ll send you our submission checklist.
Completeness Check
By the Member Secretary within 2 working days.
Assignment to Reviewers
Reviewers assess the study using standard Study Assessment Forms.
Full Committee Review
At the next scheduled meeting, with the quorum the NDCT Rules require.
Decision Letter
Within 1 working day of the meeting, where no clarifications are needed.
Ongoing Oversight
Of safety, progress and amendments until the study closes.
How the Committee Is Constituted
The committee is constituted in line with the NDCT Rules, 2019, with at least half of its members not affiliated with SER.
| Role | What they bring |
|---|---|
| Chairperson | Leads each meeting; independent of SER |
| Member Secretary | Runs submissions, the completeness check and committee records |
| Clinician | Reviews clinical risk, eligibility and participant safety |
| Medical scientist (pharmacologist) | Reviews study design, dosing and pharmacology |
| Legal expert | Reviews consent, compensation and regulatory compliance |
| Social scientist or ethicist | Brings the community and ethical perspective |
| Lay person | Checks that consent documents are clear to participants |
Frequently Asked Questions
Our site is in Gurugram or Noida. Can we use your committee?
Yes, if your site is within 50 km of our Chhatarpur office, which covers most of Delhi NCR. Share your site address and we’ll confirm.
How long does initial review take?
We check your submission for completeness within 2 working days. The full committee reviews it at the next scheduled meeting, and we issue the decision letter within 1 working day of that meeting where no clarifications are needed.
Do you review both clinical trials and BA/BE studies?
Yes. We review clinical trials and BA/BE studies conducted under the NDCT Rules, 2019.
How are review fees structured?
Fees depend on the type of study and are shared on request.
How do you handle serious adverse events and compensation?
The committee reviews every serious adverse event report, assesses causality and compensation, and reports its opinion within the timelines the NDCT Rules, 2019 set.
Planning a study in Delhi NCR?
Share your protocol synopsis and we’ll confirm our next meeting date and what to submit.

